{"symbol":"BMY","fiscalQuarter":"Q2-2008","reportDate":"2008-07-24","reportTime":"BMO","status":"reported","company":{"name":"Bristol-Myers Squibb Company","sector":"Health Care","industry":"Pharmaceuticals"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/BMY/earnings/Q2-2008","postBrief":{"headline":"Bristol Myers Squibb Reports Q2 2008 Earnings, Stock Up 1.05%","keyNumbers":[{"metric":"EPS","actual":"$0.43","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Neutral","keyQuotes":["Management did not provide specific guidance for the upcoming quarters.","The company remains focused on its core therapeutic areas."],"summary":"Management emphasized their commitment to innovation and maintaining a strong pipeline. They did not provide any updates on future guidance."},"guidanceChanges":{"summary":"No guidance data is available for this quarter.","changes":[]},"whatItMeans":"Bristol Myers Squibb's earnings report showed an EPS of $0.43, although no revenue figures were disclosed. The stock reacted positively, rising by 1.05%, likely due to the earnings figure and management's focus on their pipeline. However, the lack of guidance may leave investors cautious about future performance.","metaDescription":"Bristol Myers Squibb (BMY) Q2 2008 earnings: EPS reported at $0.43. Stock up 1.05%. Full breakdown."}}